NAD+: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits
NAD+, short for nicotinamide adenine dinucleotide, is one of the most important molecules involved in cellular energy production, metabolism, DNA repair, mitochondrial function, and cellular stress responses.
Although NAD peptide is frequently grouped with peptides in longevity, wellness, and metabolic-health discussions, it is not actually a peptide. It is a naturally occurring coenzyme present in virtually every cell in the human body.
NAD+ has attracted enormous attention because its availability may change with age and in certain metabolic or disease states. Researchers have therefore investigated whether increasing NAD+ levels might influence:
- Cellular energy
- Mitochondrial function
- Metabolic health
- Insulin sensitivity
- Exercise performance
- Brain function
- DNA repair
- Inflammation
- Healthy aging
- Age-related physical decline
NAD+-related products are now offered in several forms, including:
oral NAD+ supplements
liposomal preparations
sublingual products
intravenous NAD+ injections
and NAD+ precursors such as:
nicotinamide riboside, or NR
and
nicotinamide mononucleotide, or NMN.
The science, however, requires careful interpretation.
A major 2026 systematic review concluded that oral NR and NMN reliably increase NAD-related biomarkers in humans and appear reasonably well tolerated in short-term studies. But evidence that increasing NAD+ actually produces major improvements in longevity, metabolism, cognition, or physical performance remains inconsistent. Importantly, the review found no eligible clinical-outcome trials demonstrating that intravenous NAD+ itself provides anti-aging or wellness benefits.
What Is NAD+?
NAD+ is a coenzyme composed primarily of two nucleotides connected through their phosphate groups.
One portion contains:
adenine
and the other contains:
nicotinamide, a form of vitamin B3.
NAD exists in two major forms:
NAD+ — the oxidized form
and
NADH — the reduced form.
The ability to move back and forth between NAD+ and NADH makes the molecule exceptionally important for energy metabolism.
A simple way to think about NAD+ is as a cellular electron carrier.
It accepts electrons during metabolic reactions and becomes NADH.
NADH can later donate those electrons during reactions that help produce cellular energy.
NAD+ and Cellular Energy
One of NAD+’s most fundamental jobs involves the production of ATP, the primary energy currency of cells.
When carbohydrates, fats, and proteins are metabolized, electrons are transferred through several biochemical pathways.
NAD+ accepts many of those electrons and becomes NADH.
NADH then delivers them to the mitochondrial electron-transport chain.
This ultimately helps drive production of ATP.
The basic process can be simplified as:
Food → metabolic pathways → NADH → mitochondria → ATP
Without sufficient NAD+, many of these reactions cannot proceed efficiently.
This is one reason NAD+ is so central to cellular metabolism.
NAD+ and Mitochondria
Mitochondria depend heavily on NAD+.
These organelles are responsible for much of the body’s ATP production.
NAD+/NADH balance influences:
oxidative phosphorylation
fatty-acid metabolism
glucose utilization
and overall mitochondrial efficiency.
Mitochondrial dysfunction has been associated with numerous age-related conditions, including:
insulin resistance
cardiovascular disease
muscle decline
neurodegeneration
and metabolic dysfunction.
This has created substantial interest in whether increasing NAD+ availability might help support mitochondrial performance.
However, simply increasing NAD+ concentrations does not automatically mean mitochondria become dramatically more efficient.
Human trials of NAD+-boosting compounds have produced mixed functional results despite reliably increasing NAD-related biomarkers.
NAD+ and Aging
NAD+ has become closely associated with longevity research because numerous animal studies suggest NAD+ availability declines with age.
Scientists have proposed several reasons for this.
Aging may increase activity of enzymes that consume NAD+, including enzymes involved in:
DNA repair
inflammation
and cellular stress responses.
At the same time, NAD+ synthesis and recycling pathways may become less efficient.
Reduced NAD+ availability could theoretically contribute to:
mitochondrial dysfunction
metabolic decline
impaired DNA repair
and decreased cellular resilience.
This has led to the idea of restoring NAD+ as an anti-aging strategy.
Animal results have been impressive in some cases.
Human evidence is considerably less dramatic.
The 2026 systematic review of NAD+-boosting interventions found frequent metabolic, inflammatory, mitochondrial, and functional benefits in rodents, while human outcomes were heterogeneous and often showed little or no clinically significant benefit despite increases in NAD-related metabolites.
Does NAD+ Decline With Age?
Evidence suggests that NAD+ metabolism changes during aging, although the degree of decline varies by:
tissue
health status
metabolic condition
and the measurement method used.
This is important because statements such as “everyone loses half their NAD+ by age 50” are often repeated in marketing but do not represent a universal biological rule.
Different tissues may behave differently.
What researchers can say with much greater confidence is that NAD+ metabolism becomes altered with age and is involved in several processes associated with metabolic and cellular aging.
NAD+ and Sirtuins
One of the most popular aspects of NAD+ research involves enzymes known as sirtuins.
Sirtuins require NAD+ to function.
They influence:
gene expression
metabolic regulation
mitochondrial biology
DNA repair
and cellular responses to stress.
This connection has contributed heavily to NAD+’s longevity reputation.
Some animal research suggests that manipulating NAD+-sirtuin pathways can influence metabolic health and aspects of aging.
However, activating these pathways does not automatically translate into longer human lifespan.
There is currently no clinical evidence demonstrating that NAD+ supplementation allows humans to live substantially longer.
NAD+ and DNA Repair
DNA experiences continual damage.
Normal metabolism, radiation, oxidative stress, and environmental exposures can all damage DNA.
Cells use enzymes called PARPs, or poly(ADP-ribose) polymerases, to help repair certain forms of damage.
PARPs consume NAD+ during this process.
When cellular damage is severe, NAD+ consumption can rise substantially.
This creates another important relationship between:
cellular stress
DNA repair
and NAD+ availability.
Researchers are investigating whether maintaining adequate NAD+ availability helps cells respond more effectively to accumulated DNA damage.
What Do People Use NAD+ For?
NAD+ products are marketed for a very broad range of purposes.
The most common include:
Energy and Fatigue
Because NAD+ is directly involved in ATP production, it is commonly marketed as an energy-enhancing molecule.
The biological logic is reasonable.
However, the body regulates ATP production through many interacting systems.
There is no strong evidence that people with normal NAD+ metabolism experience a dramatic stimulant-like energy increase simply from raising NAD+ biomarkers.
Some people receiving IV NAD+ report subjective changes in energy, but controlled evidence remains limited.
Healthy Aging
This is probably the largest market surrounding NAD+.
Claims frequently include:
slower aging
better mitochondrial function
improved cellular repair
and greater longevity.
Human evidence supporting broad anti-aging benefits remains inconclusive.
A 2026 systematic review specifically concluded that while NAD+-boosting interventions clearly demonstrate biological activity, clinical effectiveness for anti-aging and wellness remains uncertain.
Metabolic Health
Because NAD+ participates in glucose and fat metabolism, researchers have investigated NAD+ precursors in:
obesity
prediabetes
insulin resistance
and type 2 diabetes.
Some studies have found improvements in selected metabolic measurements.
Others have found little meaningful effect.
A 2026 meta-analysis of randomized NMN trials found no significant overall improvements in:
body weight
BMI
fasting glucose
HbA1c
lipid profiles
or systolic blood pressure.
A small improvement in diastolic blood pressure and a trend toward better insulin resistance were observed, but broad metabolic benefits were not established.
NAD+ and Brain Health
The brain has very high energy requirements.
NAD+ therefore plays an important role in:
neuronal energy metabolism
mitochondrial function
DNA repair
and cellular stress responses.
Changes in NAD+ biology have been investigated in:
Alzheimer’s disease
Parkinson’s disease
cognitive aging
and other neurological conditions.
This has generated interest in NAD+-boosting therapies for memory and cognition.
However, human findings remain mixed.
For example, a 2025 randomized controlled trial used 2,000 mg/day of nicotinamide riboside in people with long COVID and evaluated cognition and symptom recovery. The study demonstrated biological NAD+ effects, but increasing NAD+ does not automatically establish treatment effectiveness across neurological diseases.
NAD+ and Exercise
Exercise itself strongly influences mitochondrial metabolism.
This has led researchers to investigate whether NAD+-boosting compounds can enhance:
exercise endurance
muscle function
recovery
and metabolic flexibility.
Animal findings have often been positive.
Human studies have been inconsistent.
Some trials have identified small changes in metabolic or muscular endpoints, while others have found little meaningful improvement.
There is currently insufficient evidence to describe NAD+ supplementation as a proven athletic-performance enhancer.
NAD+ Versus NR and NMN
This is one of the most important distinctions.
NAD+
This is the finished coenzyme used by cells.
NR — Nicotinamide Riboside
NR is a vitamin B3-related compound that the body can convert through metabolic steps into NAD+.
NMN — Nicotinamide Mononucleotide
NMN is another NAD+ precursor and sits one metabolic step closer to NAD+.
Both NR and NMN have been investigated extensively because they may raise intracellular NAD+ more efficiently than simply consuming intact NAD+.
Human trials consistently show that oral NR and NMN can increase NAD-related metabolites.
Whether this translates into major health improvements remains considerably less certain.
Oral NAD+
Oral supplements containing intact NAD+ are widely available.
However, intact NAD+ is a relatively large and chemically complex molecule.
Questions remain regarding:
intestinal stability
absorption
and how much intact NAD+ actually reaches systemic circulation.
The digestive system may break NAD+ into smaller components that are subsequently absorbed and recycled.
For this reason, much of modern human supplementation research focuses on NR and NMN rather than intact oral NAD+.
Nicotinamide Riboside
NR currently has one of the largest human research databases among NAD+ precursors.
Clinical trials consistently demonstrate that oral NR increases NAD-related biomarkers.
However, a critical review of human NR research concluded that clinically meaningful benefits have generally been limited and that some claims have exaggerated the strength of existing evidence.
That does not mean NR is biologically inactive.
It means:
raising NAD+ is easier to demonstrate than improving health outcomes.
Nicotinamide Mononucleotide
NMN has also become extremely popular.
Human clinical trials have generally used doses ranging from approximately:
250 mg/day
to as much as
2,000 mg/day
for periods ranging from several weeks to several months.
A 2026 systematic review and meta-analysis of 15 randomized trials found that oral NMN appeared reasonably well tolerated over the short term, with no clear increase in serious adverse events or liver-enzyme abnormalities.
However, the analysis did not find strong improvements in most major metabolic outcomes.
Again, biological activity does not necessarily equal a dramatic clinical effect.
Intravenous NAD+
Intravenous NAD+ has become increasingly common in wellness, longevity, and “biohacking” clinics.
People may receive IV NAD+ with goals involving:
energy
mental clarity
recovery
anti-aging
addiction recovery
or general wellness.
The popularity of IV NAD+ has grown much faster than the research supporting it.
A 2026 systematic review found no eligible clinical-outcome trials evaluating IV or intramuscular NAD+ itself for anti-aging or wellness indications.
That is a major distinction.
IV NAD+ is widely marketed, but its clinical effectiveness remains poorly established.
Human Research on IV NAD+
A 2026 retrospective real-world study compared intravenous NAD+ with intravenous NR.
Participants receiving IV NAD+ frequently experienced:
moderate to severe gastrointestinal symptoms
increased heart rate
and chest pressure during infusion.
Because of these reactions, NAD+ infusions required substantially longer administration times—averaging approximately 97 minutes compared with 37 minutes for IV NR.
Symptoms resolved after the infusions ended.
Researchers concluded that additional studies were needed to establish dose, safety, and effectiveness.
This is important because IV NAD+ is sometimes marketed as though it is essentially risk-free.
The human evidence does not support that assumption.
Why Are NAD+ Infusions Often Given Slowly?
People receiving IV NAD+ sometimes report uncomfortable symptoms if the infusion rate is too fast.
Reported symptoms include:
nausea
abdominal discomfort
chest pressure
increased heart rate
and a general feeling of distress.
This is consistent with the 2026 tolerability study.
The need to slow infusions significantly demonstrates that IV delivery is pharmacologically different from simply taking an oral supplement.
NAD+ Dosing Information
There is no universally FDA-approved NAD+ wellness or anti-aging dosing regimen.
The dosing landscape differs according to route.
Oral NAD+ Precursors
Human NR studies have commonly used amounts ranging from several hundred milligrams to approximately 1,000–2,000 mg/day, depending upon the trial.
NMN randomized trials have generally used approximately:
250–2,000 mg/day
for periods of roughly two weeks to 24 weeks.
These are research ranges, not a universal recommendation.
Intravenous NAD+
Commercial clinics use widely varying IV NAD+ amounts.
There is no FDA-approved standard schedule specifying:
starting dose
maintenance dose
infusion rate
frequency
or cycle length for anti-aging or wellness.
Because robust clinical outcome trials are lacking, presenting a particular IV amount as a scientifically established “optimal NAD+ dose” would be misleading.
What Forms Is NAD+ Offered In?
NAD+-related products are available in many forms.
Oral NAD+ Capsules
These contain intact NAD+ or NAD+-related compounds.
Bioavailability can vary considerably.
NR Supplements
Nicotinamide riboside is widely marketed as an oral NAD+ precursor and has substantial human biomarker data.
NMN Supplements
NMN is another widely used precursor with an expanding human research base.
Liposomal NAD+
Some products encapsulate NAD+ inside phospholipid particles with the goal of improving absorption.
Human evidence demonstrating clear superiority over conventional formulations remains limited.
Sublingual NAD+
Sublingual formulations are marketed with the goal of partially avoiding gastrointestinal degradation.
Robust comparative human bioavailability data remain limited.
Lyophilized NAD+
NAD+ may also be offered as freeze-dried or lyophilized material.
This form may appear through laboratory or compounding markets.
The existence of a sterile-looking vial does not establish that the product is pharmaceutical grade or suitable for injection.
Compounded NAD+ Injection
Compounded injectable NAD+ is offered by some pharmacies and clinics.
This area has attracted particular FDA concern.
FDA Concerns About Injectable NAD+
FDA has explicitly warned compounders about using inappropriate NAD+ ingredients for sterile injections.
The agency became aware of pharmacies using food-grade NAD+ to prepare IV products.
FDA warned that food-grade ingredients may contain microbial contamination or bacterial endotoxins and are not suitable for sterile injectable compounding without appropriate pharmaceutical processing.
FDA reported adverse reactions after NAD+ injections including:
severe chills
shaking
vomiting
and fatigue, with some patients requiring medical treatment.
These reactions were consistent with excessive endotoxin exposure.
A 2026 NAD+ Compounding Incident
The concern is not merely historical.
In January 2026, FDA issued a warning letter involving a compounding facility after three people developed:
low blood pressure
uncontrollable shaking
shivering
and body aches
during or shortly after receiving compounded NAD+.
The patients were sent to the emergency room.
An unopened vial from the same lot was later found to contain approximately 3,360 endotoxin units per milliliter, an extremely high level of bacterial endotoxin.
Again, this does not establish that NAD+ itself caused the reaction.
It demonstrates how serious manufacturing quality becomes when a product is injected directly into the bloodstream.
FDA Regulatory Status
There is no FDA-approved IV NAD+ medication for:
anti-aging
energy enhancement
brain optimization
addiction treatment
or general wellness.
As of April 2026, NAD is listed among bulk substances under evaluation for potential Section 503A pharmacy compounding.
That does not mean NAD+ is FDA-approved.
FDA has also taken enforcement action against outsourcing facilities using NAD+ under circumstances that did not meet federal compounding requirements.
Regulatory consideration for compounding and FDA approval of a drug are entirely different things.
NAD+ and Addiction Treatment
IV NAD+ is sometimes marketed for:
alcohol dependence
opioid withdrawal
drug cravings
and addiction recovery.
These claims have become particularly widespread in private wellness and detox clinics.
However, robust randomized clinical evidence demonstrating that NAD+ infusions treat substance-use disorders is lacking.
The 2026 systematic review did not identify qualifying clinical outcome trials supporting IV NAD+ for wellness or anti-aging indications, illustrating the broader shortage of controlled parenteral NAD+ research.
NAD+ should not replace established addiction treatments.
Potential Side Effects of Oral NAD+ Boosters
NR and NMN have generally been well tolerated in short-duration human research.
Possible reported symptoms can include:
- Nausea
- Gastrointestinal discomfort
- Headache
- Fatigue
- Loose stool
The 2026 NMN meta-analysis found no clear increase in:
overall adverse events
serious adverse events
or significant liver-enzyme abnormalities across short-term randomized studies.
Long-term safety over many years remains much less established.
Potential Side Effects of IV NAD+
IV administration creates a different risk profile.
Reported infusion-related symptoms include:
- Nausea
- Abdominal discomfort
- Chest pressure
- Increased heart rate
- Fatigue
- Vomiting
- Chills
- Shaking
Some of these may reflect NAD+’s pharmacological effects when infused rapidly.
Others may result from contamination or excessive bacterial endotoxin in improperly compounded preparations.
NAD+ and Cancer
The relationship between NAD+ and cancer is complicated.
Normal cells require NAD+ for:
energy
DNA repair
and survival.
Cancer cells also require NAD+.
In fact, some cancers alter NAD+ metabolism to support rapid growth and DNA repair.
This means it is overly simplistic to describe NAD+ as universally protective or universally harmful in cancer biology.
There is currently no evidence that standard NAD+-precursor supplementation causes cancer.
However, claims that dramatically increasing NAD+ prevents cancer are also unsupported.
People undergoing cancer treatment should be especially cautious about using metabolic supplements without discussing them with their oncology team.
Does NAD+ Reverse Aging?
No human clinical evidence has demonstrated that NAD+ supplementation reverses aging.
This is one of the most important distinctions in the entire NAD+ field.
Research supports the following statement:
NAD+ is essential for cellular metabolism, and NAD+ metabolism changes with age.
Evidence also supports:
NR and NMN can increase NAD-related biomarkers in humans.
The unsupported leap is:
therefore taking NAD+ or its precursors makes humans biologically younger or substantially extends lifespan.
That has not been demonstrated.
A 2026 systematic review concluded that clinical effectiveness for anti-aging and wellness outcomes remains inconclusive despite clear biochemical target engagement.
Does NAD+ Increase Energy?
NAD+ is essential for energy metabolism.
But that does not mean supplemental NAD+ acts like caffeine.
Someone who is deficient in a metabolic precursor may potentially respond differently from someone with normal NAD+ metabolism.
Clinical studies of NAD+-boosting compounds do not consistently show dramatic improvements in subjective energy or physical performance.
The relationship between cellular ATP metabolism and feeling energetic is far more complicated than the concentration of one coenzyme.
Current Research in 2026
NAD+ remains one of the most active areas in longevity and metabolic research.
Current investigators are trying to answer several increasingly specific questions:
Which people actually benefit from increasing NAD+?
Which tissues respond most strongly?
Is NR better than NMN?
Does intact NAD+ provide any advantage?
Do biomarker increases translate into clinical benefits?
What happens after years of supplementation?
A 2026 systematic review evaluating more than 100 preclinical and clinical studies concluded that human NR and NMN research consistently demonstrates biochemical effects but much more inconsistent health outcomes.
Another 2026 review similarly concluded that oral precursors can increase circulating NAD+, while IV NAD+ remains poorly characterized and lacks robust clinical validation.
This is probably the most accurate summary of where NAD+ science currently stands.
What Research Is Still Needed?
For oral NAD+-boosting strategies, researchers need larger and longer trials evaluating:
physical function
frailty
insulin sensitivity
cardiovascular disease
cognition
muscle strength
quality of life
and potentially long-term healthspan.
For IV NAD+, the needs are even more basic.
Researchers still need controlled studies establishing:
pharmacokinetics
optimal dose
infusion rate
short-term safety
long-term safety
and whether IV administration produces any clinically meaningful benefit beyond what could be achieved with oral precursors.
Until these studies exist, the popularity of NAD+ infusions will remain substantially ahead of the evidence.
The Bottom Line
NAD+ is not a peptide but a naturally occurring cellular coenzyme essential for human life.
It sits at the center of numerous biological processes involving:
energy production
mitochondrial metabolism
DNA repair
redox balance
sirtuin activity
and cellular stress responses.
There is compelling biological evidence that NAD+ metabolism changes during aging and metabolic disease.
This has made NAD+ one of the most widely discussed targets in modern longevity research.
Human research also demonstrates that oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide can successfully increase NAD-related biomarkers.
What remains much less certain is whether those biochemical changes produce major clinical benefits.
A 2026 systematic review concluded that improvements in human metabolic, cardiovascular, physical, and other healthspan-related outcomes remain inconsistent and often small or absent despite increases in NAD biomarkers.
The evidence for intravenous NAD+ is even weaker.
No robust clinical-outcome trials currently establish IV NAD+ as an effective treatment for:
anti-aging
fatigue
cognitive enhancement
addiction
or general wellness.
A recent human observational study found that IV NAD+ commonly produced moderate-to-severe gastrointestinal symptoms, increased heart rate, and chest pressure during infusions.
Manufacturing quality is another significant concern.
FDA has warned that some compounders have used food-grade NAD+ to make sterile injections and has received reports of severe reactions consistent with endotoxin contamination. In a 2026 enforcement case, several patients required emergency evaluation after receiving an NAD+ preparation that was later found to contain very high bacterial endotoxin levels.
There is therefore:
no FDA-approved NAD+ anti-aging treatment,
no FDA-approved IV NAD+ wellness protocol,
no established evidence that NAD+ supplementation extends human lifespan,
and no universal optimal NAD+ dose.
Perhaps the most accurate way to describe NAD+ in 2026 is:
an essential cellular coenzyme with unquestionably important roles in energy metabolism, mitochondrial function, DNA repair, and cellular signaling, with good evidence that certain precursors can raise NAD+ biomarkers in humans—but with much more limited evidence that increasing NAD+ produces the dramatic anti-aging, energy, cognitive, metabolic, or longevity benefits often claimed in commercial wellness settings.
For researchers, NAD+ remains extraordinarily important.
It may eventually lead to useful therapies for particular metabolic, neurological, or age-related conditions.
For consumers, however, the most important distinction is between:
proving that NAD+ is essential to cellular health
and
proving that adding extra NAD+ to an otherwise functioning system makes a person younger, healthier, or longer-lived.
The first is established science.
The second remains an active research question.
Educational notice: This article is intended for general scientific and educational information. It is not medical advice or a recommendation to use NAD+, NR, NMN, or intravenous NAD+ therapy. Published supplement doses describe research protocols rather than individualized treatment recommendations. Injectable NAD+ carries additional sterility, compounding, endotoxin, and infusion-related risks and should not be assumed equivalent to oral NAD+-boosting supplements.
